Puas yog Lanreotide Zoo tagnrho rau Neuroendocrine hlav?

Hauv cov chaw dawb huv ntawm cov chaw kuaj mob oncology, peb feem ntau hais lus hauv cov lej -CAS tus lej, Kev Ntsuas Kev Nyab Xeeb, thiab feem pua ​​​​purity. Tab sis qabLanreotide Acetate (CAS No. 127984-74-1)lies ib zaj dab neeg ntau dua. Raws li tus kws tshawb fawb ntawmXi'an Tihealth, Kuv tau pom li cas cov hluavtaws octapeptide no tau hloov zuj zus los ntawm kev xav paub hauv chav kuaj mus rau hauv lub neej rau cov neeg mob tawm tsam Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs).

Vim li cas peb tham txog qhov no niaj hnub no? Vim tias nyob rau hauv B2B ntiaj teb cov ntaub ntawv raw, qhov sib txawv ntawm 98% thiab 99.5% purity API tsis yog tus lej ntawm COA; nws yog qhov sib txawv ntawm qhov chaw kho mob ntawm tus neeg mob ruaj khov thiab cov qog rov tshwm sim. Cia peb txheeb xyuas vim li cas Lanreotide tau dav suav hais tias yog "Gold Standard" los ntawm cov kws tshaj lij thoob ntiaj teb, thiab vim li cas nws cov molecular precision yog qhov tseem ceeb heev rau kev noj qab haus huv thoob ntiaj teb.

Tau ntev, cov zej zog kho mob tau saib cov tshuaj somatostatin zoo li Lanreotide ua "palliative"-ib yam dab tsi los tiv thaiv cov dej ntws tawm thiab raws plab uas cuam tshuam nrog carcinoid syndrome. Txawm li cas los xij, raws li txhua tus kws paub txog tsiaj keeb kwm molecular yuav qhia rau koj, cov khawv koob ntawm Lanreotide nyob hauv nws txoj kev sib raug zoo rauSSTR2 thiab SSTR5 receptors.

Qhov chawCLARINET txoj kev kawmua tau zoo tso lub foob pob rau ntawm "cov tsos mob-tsuas yog" txoj kev xav. Nws tau ua pov thawj tias Lanreotide txuas ntxiv kev nce qib -dawb ciaj sia taus (PFS). Rau cov neeg mob, qhov no txhais tau hais tias lub qog tsis yog "tsim" - nws yog qhov tseem ceeb tau tuav hauv tshuaj "straitjacket." Los ntawm peb qhov kev xav ntau lawm ntawm Xi'an Tihealth, kev tswj xyuas qhov kev ncaj ncees ntawm qhov cyclic peptide no yog qhov tso cai rau qhov kev thaiv kab mob lom no tshwm sim nrog qhov tsis sib xws.

Thaum cov chaw cog tshuaj Lanreotide Acetate Powder API, lawv tsis yog yuav cov hmoov dawb xwb; lawv tab tom yuav cov txiaj ntsig kho mob. Nov yog xya qhov laj thawj uas vim li cas qhov molecule no tau txais kev pom zoo rau lub sijhawm ntev - tswj kav:

Muaj zog Anti-Proliferative Action:Nws tsis tsuas yog tswj cov tshuaj hormones; nws ncaj qha qhia cov qog hlwb kom tsis txhob faib. Nws zoo li ntaus lub pob "pause" ntawm mob qog noj ntshav.

Unmatched Ib nrab -Lub neej ruaj khov:Tsis zoo li tej yam ntuj tso somatostatin uas ploj mus hauv feeb, peb cov khoom siv hluavtaws siv sijhawm ntev txaus los tso cai rau kev noj txhua hli.

Qhov zoo ntawm "Dual{0}}Target":Los ntawm kev ntaus ob qho tib si SSTR2 thiab SSTR5, nws muab qhov dav dav ntawm kev tswj ntau dua li thawj zaug - tiam analogues.

Zoo kawg nkaus Safety Profile:Hauv kuv lub xyoo ntawm kev tshuaj xyuas peptide toxicity, Lanreotide sawv tawm. Feem ntau cov kev mob tshwm sim yog plab hnyuv thiab tswj tau, ua rau cov neeg mob ua lub neej zoo li qub.

Subcutaneous Depot muaj peev xwm:Qhov tshwj xeeb "tus kheej- sib sau ua ke" qhov xwm txheej ntawm Lanreotide molecule tso cai rau nws tsim cov nanotubes-raws li gel hauv qab ntawm daim tawv nqaij, ua kom muaj kev tso tawm tsis tu ncua yam tsis muaj qhov ncov thiab hav ntawm cov tshuaj ib txwm muaj.

Kev ua tau zoo hauv Non{0}}Cov qog ua haujlwm:Koj tsis tas yuav "ua haujlwm" qog (ib qho uas tsim cov tshuaj hormones) kom tau txais txiaj ntsig. Lanreotide ua haujlwm ntawm cov qog nqaij hlav nws tus kheej.

Sustained Quality of Life (QoL):Qhov no yog kab tias feem ntau "tib neeg" txiaj ntsig. Ntev- cov kev tshawb fawb ntev qhia tau hais tias cov neeg mob ntawm Lanreotide tuav lawv cov dej num txhua hnub thiab kev ywj pheej ua haujlwm ntev dua li cov kws kho mob hnyav.

Cia peb tau txais kev kawm ib ntus -tab sis tsis qhuav dhau, kuv cog lus. Raws li ib tug kws tshawb fawb, kuv saib covacetate cov ntsiab lusthiabresidual kuab tshuaj. Vim li cas? Vim tias yog tias API (Lanreotide Acetate Powder) muaj paug los yog degraded, "tus kheej- sib dhos" rau hauv nanotubes tau hais ua ntej ua tsis tiav.

NtawmXi'an Tihealth, peb kho txhua batch raws li yog hais tias nws tau mus rau ib tug neeg hauv tsev neeg. High -purity API kom ntseeg tau tias cov tshuaj pharmacokinetic nkhaus nyob tiaj tus. Yog tias qhov purity poob, koj tau txais "kev tso tawm tawm," uas ua rau muaj kev phiv ntau dua thiab siv sijhawm luv dua. Hauv B2B sector, "pheej yig dua" feem ntau txhais tau tias "dirtier," thiab hauv oncology, "dirty" yog ib lo lus uas peb tsuas zam tsis tau.

Koj puas tau xav tias yog vim li cas Lanreotide tsis xav tau cov khoom siv polymer ua kom nyob hauv lub cev 28 hnub? Nws yog vim lub molecule yog ib tug overachiever. Thaum muaj zog, Lanreotide molecules spontaneously npaj rau hauv ntev, hollow nanotubes.

Rau cov kws tshuaj formulator nyeem qhov no: qhov no yog vim li cas koj xaiv API yog txhua yam. Txhua yam impurity nyob rau hauv lub peptide ib ntus tuaj yeem ua "knot" hauv lub raj no, ua rau lub viscosity thiab qhov tso tawm. Peb tsis yog synthesize ib molecule xwb; peb curate ib tug qauv. Qhov no "ntse" tus cwj pwm ntawm Lanreotide molecule yog dab tsi ua rau nws yog ib tug masterpiece ntawm niaj hnub tshuaj chemistry.

Thaum kuv xav qhia rau koj tias nws yog rab phom khawv koob, tus kws tshawb fawb tseeb yuav tsum nyob twj ywm lub hom phiaj. Lanreotide yog qhov zoo tshaj plaws rauQib 1 thiab Qib 2 GEP-NETs. Rau kev txhoj puab heev, Qib 3 qog nqaij hlav, nws feem ntau ua raws li tus neeg txhawb nqa es tsis yog tus thawj coj.

Txawm li cas los xij, nws lub luag haujlwm hauv lub voj voog "Theranostic" tab tom loj hlob. Peb tab tom pom ntau tus kws tshawb fawb siv Lanreotide ua lub hauv paus thaum muab cov kev kho tshiab zoo li PRRT (Peptide Receptor Radionuclide Therapy). Nws yog lub hauv paus txhim khu kev qha-"Kev Ntseeg Laus" ntawm lub ntiaj teb peptide- uas tso cai rau lwm cov kev kho mob hnyav dua ua haujlwm kom nyab xeeb dua.

Hauv ntiaj teb ntawm Google EEAT, kev ntseeg siab tau tsim los ntawm kev pom tseeb. Peb cov kab ntau lawm rau Lanreotide Acetate ua haujlwm hauv qabISO9001: 2015cov qauv, tab sis nws mus dhau kev ua raws cai. Peb siv HPLC siab heev thiab Mass Spectrometry los xyuas kom meej tias txhua milligram ntawm cov hmoov ua tau raws li qhov tseeb molecular hnyav thiab raws li qhov yuav tsum tau ua.

Peb nkag siab tias rau peb cov neeg koom tes B2B-txawm lawv yog siab heev-khoom noj khoom haus lossis chaw kuaj tshuaj- API yog qhov tseem ceeb ntawm lawv lub koob npe nrov. Los ntawm kev ua raws li "Cov Neeg Siv Khoom-Cov Txheej Txheem Kev Noj Qab Haus Huv Kev Noj Qab Haus Huv," peb txuas qhov sib txawv ntawm cov peptide synthesis thiab tiag- kev saib xyuas neeg mob hauv ntiaj teb.

Thaum kawg ntawm hnub, Lanreotide Acetate tsis yog tsuas yog nkag rau hauv phau ntawv teev npe. Nws yog qhov tshwm sim ntawm kaum xyoo ntawm kev tshawb fawb endocrine thiab cov tshuaj lom neeg muaj tseeb. Puas yog zoo tagnrho? Rau ntau lab tus tib neeg tawm tsam nrog GEP-NETs thiab acromegaly, nws yog ze rau "zoo tagnrho" raws li kev tshawb fawb niaj hnub tam sim no tso cai.

NtawmXi'an Tihealth Biotechnology Co., Ltd., peb tsis yog muab cov ntaub ntawv raw; peb muab lub tsev blocks ntawm lub neej zoo dua. Peb caw peb cov neeg koom tes thoob ntiaj teb los koom nrog peb hauv txoj haujlwm no -vim thaum peb tau txais kev tshawb fawb zoo, cov neeg mob tau txais lawv txoj sia rov qab los.

The New England Journal of Medicine (NEJM): Lanreotide hauv Metastatic Enteropancreatic Neuroendocrine Tumors (CLARINET Study).

https://www.nejm.org/doi/full/10.1056/NEJMoa1316158

Phau ntawv Journal of Clinical Oncology (ASCO): Kev tshuaj xyuas ntawm cov tshuaj tiv thaiv -proliferative teebmeem ntawm Lanreotide.

https://ascopost.com/issues/january-25-2015/lanreotide-in-gastroenteropancreatic-neuroendocrine-tumors/

PubChem (NCBI): Cov ntsiab lus sib xyaw rau Lanreotide Acetate (CAS 127984-74-1).

https://pubchem.ncbi.nlm.nih.gov/compound/Lanreotide-acetate

European Society for Medical Oncology (ESMO): Cov lus qhia rau kev tswj hwm ntawm GEP-NETs.

https://www.esmo.org/guidelines/gastrointestinal-cancers/neuroendocrine- qog

ScienceDirect: Self- sib dhos ntawm octapeptide Lanreotide rau hauv nanotubes.

https://www.sciencedirect.com/science/article/abs/pii/S002228360300901X